Member Info for Bridgedogg1

Even if the 'Swiss banker' hands over £7m its barely enough to get Vast out of the hole it is in. Vast has raised £6m in the last year alone to literally no effect other than to pay wages.

Due to the amount of info in the accounts update I expect they will want to make announcements on other news flow in separate RNS.

• increasing production from BNG, Block 8 & West Shalva;

• sale of the MJF and South Yelemes $83 million gross proceeds;

• the start of production revenues from Block 8 and West Shalva;

• continued oil trading profit; and

• receipt of income from the first commercial drilling charter for Caspian Explorer

Shallow drilling rig owned by Caspian replacement rig cost estimated at $300m.

CTS owns 4 rigs, being one G50, two G40s, and a G20 workover rig, with the number indicating the maximum drill string weight the rig can support. Negotiations to acquire a G70 rig, which will allow future faster drilling of deep wells, are at an advanced stage.

Caspian Explorer - we expect to receive at least a further $10 million in the next few months in addition to the upfront payments already received - how much annual revenue will this generate!?

Potential farm in on deeps indicated:"To date, in aggregate, approaching $200 million has been spent on the BNG Contract Area of which the Group has spent approximately $120 million, most of which was spent on the deep structures. Any corporate activity in respect of the deep structures at the BNG Contract Area would need to reflect both the gross investment made to date and the Contract Area’s future prospects as evidenced by expected future production levels and reserves."

The BNG deep wells have 80mbbls of oil to exploit/sell.

Block 8 "a second potentially transformative asset in that either or both could enjoy the same geological characteristics of the nearby world class Tengiz and Kashagan assets."

"Our investment in CTS with its ability to drill several deep wells at the same time has led to early stage discussions

for the Group to farm into an existing asset in return for CTS drilling wells to help that third party meet existing work

programme obligations that may otherwise be missed"

"The current BNG work programme commitments are now largely satisfied. Block 8 is expected to start contributing

in the near future and significant income is expected from the Caspian Explorer in the coming months. Accordingly,

we expect soon to enter a prolonged period where cash receipts far exceed mandated cash payments. In the event we

complete the proposed sale of the BNG shallow structures for the proposed $83 million we would have large cash

balances to invest or to return to shareholders via special dividends or share buy backs."

Very much a very exciting time for the company. When will the market start to see the true value here?

Whoosh

The information was in the previous updates for those that read them Huge sale of shallow while retaining the better deeps which are about to report on flow testing a previously unidentified horizon, with 2 more targets yet to be tested below the salt layer. We'll have £100m to develop that asset. Not to mention fingers in the other pies.

Topped up at 4.25, think this will move back to the 7-9p range this month

What helium?

Re Deep Well 803, currently testing the 60 meter interval between 3,360 meters and 3,420 meters, with the ‘primary target at a depth of 3,950 meters with a secondary target at a depth of 4,200 meters’ also still be tested do we know?

Oil has been detected over a 60 meter interval between 3,360 meters and 3,420 meters, above expectations and also above the main salt layer.

When is the next 2bn shares hitting holders in the nuts?

People are still buying this!?!! Aim really is a casino full of chancers. Shares in issue about to double fir £600k and no update on the fabricated life lines - diamonds/swiss etc. surely this must fall below 0.1 now

Faron will be hosting a virtual webinar to discuss the FDA feedback and updated clinical development plans July 15th, at 15.00 EEST / 13.00 BST.

To register for the event visit: https://faron.videosync.fi/fda-feedback-update

These devices are already sold into a number of other countries, this opens up another 1000 patients per year, I don’t believe they are hugely revenue generating? Nice bit of news though.

Previously targeting only relapsed / refractory MDS now looking at self funded P3 frontline MDS. Can’t wait for the new numbers on this. Wouldnt mind comments on some speculation:

Previously looking for a comercial deal to get P3 r/r MDS targeting around 4,000 patient population per year in the US. Now looking to possibly self fund P3 targeting 20,000 patient population or year, a 500% increase in all projected figures with a timeline reduced by years and costs reduced by £100m or so.

Just speculation on my part and hopefully tomorrows presentation will bear this out but that’s got to be worth an easy £billion on top of the old target valuations. I expect it won’t be too difficult to rerun the modelling to generate some numbers.

“The FDA noted that given the relatively modest efficacy of single agent azacitidine and the current response rates with bexmarilimab that the size of such a frontline study may not have to be substantially larger than the proposed study in the r/r setting.”

I just like reading it. Less costs, faster timeliness FDA basically saying ‘we know it works, we know it’s better than current treatments, bring it to market ASAP, we will do whatever we can to help’

Just the start here, the discounted raise has gifted an opportunity to get in here before it moves to a £b valuation or a £bx2 buyout. We should see plenty of 20% days ahead.

Should be smashing all time highs with that news, luckily for the uninvested we are languishing near all time lows.

What a bargain.

Https://www.cityam.com/government-denies-ed-miliband-has-banned-new-north-sea-oil-licences/

Yes it would be a shame if someone came in now with a £350m offer, they would probably get it for £500m in the end. Need to get this share price up.

Good question.

Certainly we are in a much stronger position now.

‘Panicked shorters’ ? Of prem?

They are rolling in it and waiting for the next placing

Would expect this to do atleast 5-10% daily until it gets to the £3 mark.

Hurdles

2.2p (broken?)

2.5p

3p (small)

3.2p

4p

5p

Plenty of gaps there to jump us up fairly quickly. Most would have seen what Avacta has achieved after their raise, we can do the same here, and with more immediate -company changing -news flow.

How is it being held back with all these buys!!?!??!